Abstract: The present invention discloses a novel approach to attenuating bacteria and for their use as live vaccines. The vaccines can be used in human and animal medicine.In particular, there is disclosed a method of attenuating a bacteria by mutating a gene concerned with the regulation of one or more genes concerned with expression of outer membrane proteins, particularly porin proteins.
Type:
Grant
Filed:
April 10, 1995
Date of Patent:
December 22, 1998
Assignees:
Glaxo Wellcome Inc., The Royal Society, The Lister Institute of Preventive Medicine, The University Court of The University of Dundee
Inventors:
Gordan Dougan, Steven Neville Chatfield, Christopher Francis Higgins, Charles James Dorman
Abstract: The present invention discloses a novel approach to attenuating bacteria and for their use as live vaccines. The vaccines can be used in human and animal medicine.In particular, there is disclosed a method of attenuating a bacteria by mutating a gene concerned with the regulation of one or more genes concerned with expression of outer membrane proteins, particularly porin proteins.
Type:
Grant
Filed:
April 10, 1995
Date of Patent:
June 18, 1996
Assignees:
The Wellcome Foundation Limited, The Royal Society, The Lister Institute of Preventive Medicine, The University Court of The University of Dundee
Inventors:
Gordan Dougan, Steven N. Chatfield, Christopher F. Higgins, Charles J. Dorman